Literature DB >> 25427698

Chemotherapy education for patients with cancer: a literature review.

Ramsey B Valenti1.   

Abstract

A literature review was conducted to determine the best way to provide chemotherapy education to patients. Sixteen articles that employed various teaching methods (e.g., video recordings, in-person class) were identified. Some educational methods have been proven to decrease anxiety, which allows patients to retain more information. Many ways can be used to provide chemotherapy education, and no method has been proven to be significantly more effective than another. Maximum retention is largely based on patient preference.

Entities:  

Keywords:  anxiety; chemotherapy; patient education; retention

Mesh:

Year:  2014        PMID: 25427698     DOI: 10.1188/14.CJON.637-640

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  9 in total

1.  Evaluation of a Nurse-Delivered Pre-Chemotherapy Educational Intervention to Increase Knowledge and Reduce Anxiety Among Ethnically Diverse Patients.

Authors:  Sarah E Piombo; Kimberly A Miller; Kaitlin Alderete; Alden Egan; Sally Golingay; Thomas W Valente
Journal:  J Cancer Educ       Date:  2021-08       Impact factor: 2.037

2.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.

Authors:  Ramaswamy Govindan; Charu Aggarwal; Scott J Antonia; Marianne Davies; Steven M Dubinett; Andrea Ferris; Patrick M Forde; Edward B Garon; Sarah B Goldberg; Raffit Hassan; Matthew D Hellmann; Fred R Hirsch; Melissa L Johnson; Shakun Malik; Daniel Morgensztern; Joel W Neal; Jyoti D Patel; David L Rimm; Sarah Sagorsky; Lawrence H Schwartz; Boris Sepesi; Roy S Herbst
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

3.  Factors influencing chemotherapy knowledge in women with breast cancer.

Authors:  Pearman D Parker; Sue P Heiney; Swann Arp Adams; Daniela B Friedman; Robin M Dawson
Journal:  Appl Nurs Res       Date:  2020-07-23       Impact factor: 2.257

4.  The timeliness of patients reporting the side effects of chemotherapy.

Authors:  Ian Olver; Mariko Carey; Allison Boyes; Alix Hall; Natasha Noble; Jamie Bryant; Justin Walsh; Rob Sanson-Fisher
Journal:  Support Care Cancer       Date:  2018-05-03       Impact factor: 3.603

5.  How are health literacy principles incorporated into breast cancer chemotherapy education? A review of the literature.

Authors:  Pearman D Parker; Sue P Heiney; Daniela B Friedman; Tisha M Felder; Robin Dawson Estrada; Eboni Herbert Harris; Swann Arp Adams
Journal:  J Nurs Educ Pract       Date:  2018-01-16

6.  Antitumor Activity of Royal Jelly and Its Cellular Mechanisms against Ehrlich Solid Tumor in Mice.

Authors:  Aishah E Albalawi; Norah A Althobaiti; Salma S Alrdahe; Reem Hasaballah Alhasani; Fatima S Alaryani; Mona N BinMowyna
Journal:  Biomed Res Int       Date:  2022-04-11       Impact factor: 3.246

7.  2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.

Authors:  Emily Mackler; Eve M Segal; Benyam Muluneh; Kate Jeffers; Jenna Carmichael
Journal:  J Oncol Pract       Date:  2019-03-12       Impact factor: 3.840

8.  Anti-Tumor Effects of Queen Bee Acid (10-Hydroxy-2-Decenoic Acid) Alone and in Combination with Cyclophosphamide and Its Cellular Mechanisms against Ehrlich Solid Tumor in Mice.

Authors:  Aishah E Albalawi; Norah A Althobaiti; Salma Saleh Alrdahe; Reem Hasaballah Alhasani; Fatima S Alaryani; Mona Nasser BinMowyna
Journal:  Molecules       Date:  2021-11-20       Impact factor: 4.411

9.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer.

Authors:  Ann W Silk; Christopher A Barker; Shailender Bhatia; Kathryn B Bollin; Sunandana Chandra; Zeynep Eroglu; Brian R Gastman; Kari L Kendra; Harriet Kluger; Evan J Lipson; Kathleen Madden; David M Miller; Paul Nghiem; Anna C Pavlick; Igor Puzanov; Guilherme Rabinowits; Emily S Ruiz; Vernon K Sondak; Edward A Tavss; Michael T Tetzlaff; Isaac Brownell
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.